Under construction – not a live service
Sign in
Not yet recruitingPhase 2/3

Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin

Key facts

Phase
Phase 2/3

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 80 years old?

Source: NCT07047040, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT07047040
Record updated
1 August 2025
Original description
Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKARead full original descriptionShow less

Analgesic Efficacy of Pre-operative Dose of Ketorolac And Gabapentin in Patients Undergoing Unilateral Total Knee Arthroplasty A Randomized Double Blinded Controlled Trial

Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA

Inclusion: Patients Undergoing Unilateral Total Knee Replacement from 40 years old to 80 years old.

Exclusion: Rheumatoid Arthritis History of Renal impairment Patients refused to be enrolled in the study.

ClinicalTrials.gov NCT07047040